Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Biomarkers in Medicine
|
May 19, 2010
Surrogate end points: how well do they represent patient-relevant end points?
Marco M Jost
Lab Animal
|
February 1, 2006
Experimental models of arteriogenesis: differences and implications
Imo E Hoefer, Niels van Royen, Marco M Jost
Lab Animal
|
August 31, 2004
Discrimination of heterozygous from wild-type mice bearing a mutation in the macrophage-colony-stimulating factor gene using capillary electrophoresis
Dieter Techel, Caroline Bergmann, Ivo Buschmann, et al.
Combinatorial Chemistry & High Throughput Screening
|
February 9, 2006
The concept of functional peptidomics for the discovery of bioactive peptides in cell culture models
Marco M Jost, Petra Budde, Harald Tammen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 4, 2003
Divergent effects of GM-CSF and TGFbeta1 on bone marrow-derived macrophage arginase-1 activity, MCP-1 expression, and matrix metalloproteinase-12: a potential role during arteriogenesis
Marco M Jost, Elena Ninci, Benjamin Meder, et al.
Journal of Leukocyte Biology
|
May 11, 2006
Arteriogenesis depends on circulating monocytes and macrophage accumulation and is severely depressed in op/op mice
Caroline E Bergmann, Imo E Hoefer, Benjamin Meder, et al.
Cardiovascular Research
|
October 16, 2004
Differential effects of MCP-1 and leptin on collateral flow and arteriogenesis
Stephan H Schirmer, Ivo R Buschmann, Marco M Jost, et al.
Biochemical Pharmacology
|
October 23, 2008
In vivo profiling of DPP4 inhibitors reveals alterations in collagen metabolism and accumulation of an amyloid peptide in rat plasma
Marco M Jost, Jens Lamerz, Harald Tammen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Biomarkers in Medicine
|
May 19, 2010
Surrogate end points: how well do they represent patient-relevant end points?
Marco M Jost
Lab Animal
|
February 1, 2006
Experimental models of arteriogenesis: differences and implications
Imo E Hoefer, Niels van Royen, Marco M Jost
Lab Animal
|
August 31, 2004
Discrimination of heterozygous from wild-type mice bearing a mutation in the macrophage-colony-stimulating factor gene using capillary electrophoresis
Dieter Techel, Caroline Bergmann, Ivo Buschmann, et al.
Combinatorial Chemistry & High Throughput Screening
|
February 9, 2006
The concept of functional peptidomics for the discovery of bioactive peptides in cell culture models
Marco M Jost, Petra Budde, Harald Tammen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 4, 2003
Divergent effects of GM-CSF and TGFbeta1 on bone marrow-derived macrophage arginase-1 activity, MCP-1 expression, and matrix metalloproteinase-12: a potential role during arteriogenesis
Marco M Jost, Elena Ninci, Benjamin Meder, et al.
Journal of Leukocyte Biology
|
May 11, 2006
Arteriogenesis depends on circulating monocytes and macrophage accumulation and is severely depressed in op/op mice
Caroline E Bergmann, Imo E Hoefer, Benjamin Meder, et al.
Cardiovascular Research
|
October 16, 2004
Differential effects of MCP-1 and leptin on collateral flow and arteriogenesis
Stephan H Schirmer, Ivo R Buschmann, Marco M Jost, et al.
Biochemical Pharmacology
|
October 23, 2008
In vivo profiling of DPP4 inhibitors reveals alterations in collagen metabolism and accumulation of an amyloid peptide in rat plasma
Marco M Jost, Jens Lamerz, Harald Tammen, et al.
Page
of 1